A carregar...
Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges
Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder, is typified by both motor and nonmotor symptoms. The current medications provide symptomatic relief but do not stimulate the production of new dopaminergic neurons in the substantia nigra. Astrocyte reprogramming has rec...
Na minha lista:
| Publicado no: | Sci Adv |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Association for the Advancement of Science
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221613/ https://ncbi.nlm.nih.gov/pubmed/34162545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abg3198 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|